Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 111

Results For "2022"

1413 News Found

Dr. Reddy's and MediCane Health launch medical cannabis in Germany
Biotech | April 03, 2022

Dr. Reddy's and MediCane Health launch medical cannabis in Germany

The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021


New data indicate molnupiravir eliminates Covid-19 rapidly
Biotech | April 03, 2022

New data indicate molnupiravir eliminates Covid-19 rapidly

Among patients with infectious virus at baseline, no patients who received Lagevrio had infectious virus at days 3, 5 or 10


Wipro GE Healthcare launches facility under govt’s PLI scheme
News | April 01, 2022

Wipro GE Healthcare launches facility under govt’s PLI scheme

It is one of the 15 medical device manufacturers approved under the government’s PLI scheme


Dr Shravan Subramanyam, MD, Wipro GE Healthcare elected NATHEALTH President
News | April 01, 2022

Dr Shravan Subramanyam, MD, Wipro GE Healthcare elected NATHEALTH President

Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India


Oragnon enters global licencing agreement with Dare Biosciences
News | April 01, 2022

Oragnon enters global licencing agreement with Dare Biosciences

An estimated 21 million American women experience BV


Sumitomo Chemical to build new API and intermediates plant in Japan
News | April 01, 2022

Sumitomo Chemical to build new API and intermediates plant in Japan

The plant is scheduled to come on stream in September 2024


Evonik restructures health care business
News | April 01, 2022

Evonik restructures health care business

The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries


USFDA seeks more analysis on Merck’s BLA for Vaxneuvance
Biotech | April 01, 2022

USFDA seeks more analysis on Merck’s BLA for Vaxneuvance

No new studies have been requested


Dr. Reddy's to acquire cardiovascular brand Cidmus in India
News | April 01, 2022

Dr. Reddy's to acquire cardiovascular brand Cidmus in India

The Cidmus brand shall be affixed on the pharmaceutical composition comprising a combination of Valsartan and Sacubitril (currently under Novartis patent) which is indicated for heart failure patients with reduced ejection fraction


CerroZone reduces airborne Covid-19 Delta variant by 99.998% in 1.2 seconds
Biotech | March 31, 2022

CerroZone reduces airborne Covid-19 Delta variant by 99.998% in 1.2 seconds

Air purification system achieves Intertek zero ozone certification